<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Bristol Myers betaler $11 mia for halvpart i Biontech middel]]></title><description><![CDATA[<p dir="auto">&quot;Bristol Myers Squibb is paying BioNTech $3.5 billion to board the PD-1/L1xVEGF-A bandwagon. The deal, which features up to $7.6 billion in milestones, gives BMS a 50% stake in one of the leading candidates in the hottest area of immuno-oncology.&quot;</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.fiercebiotech.com/biotech/bristol-myers-inks-11b-biontech-deal-join-bispecific-gold-rush-leaping-ahead-merck-and">
Access denied | www.fiercebiotech.com used Cloudflare to restrict access | www.fiercebiotech.com | Cloudflare
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.fiercebiotech.com/biotech/bristol-myers-inks-11b-biontech-deal-join-bispecific-gold-rush-leaping-ahead-merck-and" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.fiercebiotech.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.fiercebiotech.com)</span></p>
</a>
</div></p>
<p dir="auto">Det er lige knap halvdelen af Biontechs marketcap, som i øvrigt stort set er dækket af kontanter.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/447336/bristol-myers-betaler-11-mia-for-halvpart-i-biontech-middel</link><generator>RSS for Node</generator><lastBuildDate>Sat, 13 Jun 2026 03:30:19 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/447336.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 02 Jun 2025 13:56:13 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Bristol Myers betaler $11 mia for halvpart i Biontech middel on Fri, 06 Jun 2025 20:32:24 GMT]]></title><description><![CDATA[<p dir="auto">Ivonescimab fra Summit Therapeutics er ogsaa en PD-1/VEGF-A inhibitor. Den er indtil videre kun godkendt i Kina.</p>
<p dir="auto">2024-05-31<br />
<a href="https://www.smmttx.com/pressrelease/ivonescimab-in-combination-with-chemotherapy-approved-in-china-by-nmpa-for-2l-egfrm-nsclc-based-on-harmoni-a-clinical-trial-positive-trend-observed-in-overall-survival-towards-ivonescimab-plus-chemo/" rel="nofollow ugc">https://www.smmttx.com/pressrelease/ivonescimab-in-combination-with-chemotherapy-approved-in-china-by-nmpa-for-2l-egfrm-nsclc-based-on-harmoni-a-clinical-trial-positive-trend-observed-in-overall-survival-towards-ivonescimab-plus-chemo/</a><br />
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9493112</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9493112</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Fri, 06 Jun 2025 20:32:24 GMT</pubDate></item><item><title><![CDATA[Reply to Bristol Myers betaler $11 mia for halvpart i Biontech middel on Mon, 02 Jun 2025 19:27:16 GMT]]></title><description><![CDATA[<p dir="auto">Også den her nyhed fra i dag trods et temmelig dødt M&amp;A-landskab:</p>
<p dir="auto">Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B<br />
<a href="https://endpoints.news/sanofi-to-snap-up-blueprint-medicines-and-mastocytosis-drug-ayvakit-for-9-1b/" rel="nofollow ugc">https://endpoints.news/sanofi-to-snap-up-blueprint-medicines-and-mastocytosis-drug-ayvakit-for-9-1b/</a></p>
<p dir="auto">Relateret til BMS vedhæftet figur med kvartalsvise globale salgstal for PD-1-inhibitoren Opdivo.</p>
<p dir="auto"><img src="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/126605_BMY_us_gaap.Revenues_us_gaap.ProductOrService_bmy.Opdivo.png" alt="126605_BMY_us_gaap.Revenues_us_gaap.ProductOrService_bmy.Opdivo.png" class=" img-fluid img-markdown" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9493113</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9493113</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Mon, 02 Jun 2025 19:27:16 GMT</pubDate></item></channel></rss>